








asof: 2025-12-03
Bandhan Bank (BANDHANBNK) Analysis: Headwinds, Tailwinds, Growth Prospects, and Key Risks
Bandhan Bank, a mid-sized private sector bank with roots in microfinance (EEB segment), is undergoing portfolio diversification amid asset quality challenges. Q2FY26 results (ended Sep 2025) show muted growth and profitability, but improving mix and balance sheet strength. Total assets ~₹1,950 bn, advances ₹1,400 bn (7% YoY), deposits ₹1,581 bn (11% YoY). Below is a structured summary based on disclosures (earnings presentation, GST order, NPA sale, etc.).
Tailwinds (Positive Catalysts)
Headwinds (Challenges)
Growth Prospects (Medium-Term Opportunities)
Projected Trajectory: Advances/deposits growth 12-15% FY26E (industry ~15%); NIM stabilization at 5.5-6%; RoA recovery to 1%+ by FY27 if asset quality improves. Valuations attractive (low TEVABV ~0.8x).
Key Risks
| Risk Category | Description | Mitigation |
|---|---|---|
| Asset Quality | GNPA 5.0% (up QoQ), NNPA 1.4%; EEB slippages ₹16 bn/Q; credit cost 3.4% (high). Vintage analysis shows older cohorts stressed. | NPA sales to ARCs; collections >97%; secured shift; PCR 74%. |
| Regulatory | GST demand ₹2.2 Cr (FY19-23; appeal planned, no material impact). RBI domain migration done; director approvals via postal ballot. | Strong compliance; no major violations noted. |
| Profitability/NIM | NIM down 55 bps QoQ; high provisions (₹11.5 bn/Q). | Deposit accretion; yield optimization. |
| Execution | EEB cleanup dependency; competition in wholesale/retail from larger peers. | Experienced mgmt (40+ yr avg); diversification. |
| Macro | Slow economy/microfinance stress; rate cuts may help NIM but hurt yields. | Diversified book (62% non-East). |
| Concentration | EEB still ~37%; promoter nominee dynamics. | Ongoing de-risking. |
Overall Outlook: Neutral to Positive. Headwinds from legacy NPAs/profitability dominate short-term, but tailwinds from diversification/digital/deposit strength position for recovery. NPA sale outcome critical. Monitor Q3FY26 for traction. At current levels, stock offers value for patient investors (DY ~1.5%; PB ~0.7x FY26E).
Data as of Q2FY26 (Sep 2025); sources: Earnings deck, disclosures.
Copyright © 2023 SAS Data Analytics Pvt. Ltd. All rights reserved.